Encompass Health Corporation $EHC Shares Bought by MGO One Seven LLC

MGO One Seven LLC lifted its stake in shares of Encompass Health Corporation (NYSE:EHC) by 56.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,382 shares of the company’s stock after buying an additional 1,581 shares during the quarter. MGO One Seven LLC’s holdings in Encompass Health were worth $537,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. WPG Advisers LLC acquired a new position in shares of Encompass Health during the first quarter worth about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares in the last quarter. Park Place Capital Corp acquired a new position in shares of Encompass Health during the second quarter worth about $72,000. Arlington Trust Co LLC grew its position in shares of Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock worth $68,000 after buying an additional 125 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its position in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

EHC has been the subject of a number of analyst reports. UBS Group boosted their price objective on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. KeyCorp boosted their target price on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 16th. Truist Financial boosted their target price on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research note on Thursday, August 14th. Finally, Bank of America boosted their target price on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. One analyst has rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $139.86.

Encompass Health Price Performance

Shares of NYSE EHC opened at $124.55 on Friday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.86. The stock has a 50 day moving average of $123.56 and a two-hundred day moving average of $117.15. The stock has a market cap of $12.55 billion, a P/E ratio of 24.37, a P/E/G ratio of 2.15 and a beta of 0.93.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a $0.19 dividend. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Wednesday, October 1st. Encompass Health’s dividend payout ratio (DPR) is presently 14.87%.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.